Latest IONS reports update at 2024-05-07: 2024-Q12023-Q42023-Q1
Ionis Pharmaceuticals logo
Ionis Pharmaceuticals IONS
$ 39.47 -1.72%

Ionis Pharmaceuticals Financial Statements 2011-2024 | IONS

Annual Financial Statements Ionis Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

6.26 B 5.23 B 4.48 B 8.39 B 8.34 B 7.4 B 6.54 B 5.06 B 4.66 B 8.06 B 5.52 B 1.48 B 821 M

Shares

143 M 142 M 141 M 140 M 140 M 132 M 124 M 121 M 120 M 118 M 111 M 101 M 99.7 M

Historical Prices

43.7 36.9 31.8 60.1 58.3 58 52.5 44.5 38.9 68.5 51.1 14.5 8.16

Net Income

-9.26 M -52.4 M -28.6 M -444 M 294 M 274 M -5.97 M -86.6 M -88.3 M -39 M -60.6 M -65.5 M -84.8 M

Revenue

325 M 152 M 810 M 729 M 1.12 B 600 M 508 M 347 M 284 M 214 M 147 M 102 M 99.1 M

Cost of Revenue

9.13 M 14.1 M 10.8 M 11.9 M 4.38 M 1.82 M - - - - - - -

Gross Profit

- - - - 1.12 B 598 M 133 M 2.3 M -38.6 M -27.6 M -36.7 M -56.4 M 99.1 M

Operating Income

-6.12 M -208 M -30.2 M -172 M 366 M -61.4 M 31 M -20.2 M -75.8 M -47.7 M -51.7 M -68.9 M -71.1 M

Interest Expense

12.7 M 8.12 M 9.35 M 9.51 M 12.4 M 44.8 M 44.8 M 38.8 M 36.7 M 22.2 M 19.4 M 21.2 M 16.7 M

EBITDA

4.17 M -194 M -14.7 M -159 M 382 M -48.8 M 32.9 M -37.3 M -65.5 M -38.3 M -41.9 M -58.2 M -59.3 M

Operating Expenses

- - - - 752 M 659 M 483 M 393 M 359 M 262 M 199 M 171 M 170 M

General and Administrative Expenses

233 M 150 M 186 M 354 M 287 M 245 M 108 M 48.6 M 37.2 M 20.1 M 14.9 M 12.5 M -

All numbers in USD currency

Quarterly Income Statement Ionis Pharmaceuticals

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

146 M 144 M 143 M 143 M 143 M 142 M 142 M 142 M 142 M 141 M 141 M 141 M 141 M 140 M 140 M 139 M 139 M 141 M 141 M 140 M 139 M 138 M 137 M 129 M 125 M 125 M 124 M 124 M 123 M 121 M 121 M 121 M 121 M 120 M 120 M 120 M 119 M 118 M 118 M 118 M 117 M 116 M 115 M 109 M 102 M 101 M 101 M 100 M 100 M 100 M 99.7 M 99.6 M 99.6 M

Net Income

-143 M - -147 M -85.3 M -124 M - -47 M -105 M -65.2 M 225 M -82.5 M -80.9 M -89.9 M -355 M -24.5 M -25.6 M -39.6 M 184 M 26.2 M -876 K 84.4 M 320 M -4.56 M -40.4 M -1.42 M -2.92 M -2.61 M -3.08 M 8.96 M 25.9 M 7.35 M -56.9 M -62.9 M -71.4 M -35.8 M 35.6 M -16.7 M 31.1 M -26.7 M -12.1 M -31.3 M -24.3 M -36.4 M -11.8 M -1.67 M -2.64 M -37.6 M -1.21 M -24 M -20 M -26.9 M -17.9 M -20 M

Revenue

119 M - 144 M 188 M 131 M - 160 M 134 M 142 M 440 M 133 M 126 M 112 M 290 M 160 M 146 M 133 M 494 M 168 M 164 M 297 M 192 M 145 M 118 M 144 M 168 M 118 M 112 M 116 M 160 M 111 M 38.5 M 36.9 M 51.6 M 49.1 M 120 M 62.6 M 84.9 M 44.1 M 57.1 M 28.2 M 42.2 M 23.6 M 38.1 M 43.4 M 19.9 M 11.6 M 47.3 M 23.2 M 32.4 M 20.7 M 24.8 M 21.1 M

Cost of Revenue

2.15 M - 2.19 M 2.54 M 1.34 M - 1.52 M 4.74 M 4.17 M - 3.08 M 2.96 M 2.58 M - 3.09 M 3.01 M 2.55 M - 967 K 1.36 M 1.04 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-150 M - -143 M -90.2 M -114 M - -59.2 M -85.5 M -57.5 M 221 M -85.8 M -73 M -92 M -22.7 M -36.5 M -51.8 M -61.1 M 261 M 2.52 M -18.8 M 122 M 10.8 M -18.6 M -50.3 M -3.3 M -6.2 M 11.3 M 6.45 M 19.5 M 41.2 M 16.1 M -48.9 M -54.7 M -62.9 M -48.1 M 44.6 M -9.33 M 10.1 M -21.5 M -6.65 M -29.7 M -19.9 M -25.5 M -7.93 M 1.62 M -26.1 M -28 M 3.7 M -18.5 M -18.6 M -22.3 M -14.1 M -16.1 M

Interest Expense

4.15 M - 4.2 M 2.29 M 1.61 M - 2.14 M 2.13 M 2.12 M - 2.34 M 2.36 M 2.41 M - 2.43 M 2.44 M 2.21 M - 12 M 11.8 M 11.6 M - 11.3 M 11.1 M 10.9 M - 10.8 M 11.8 M 11.4 M - 9.75 M 9.62 M 9.49 M - 9.23 M 9.13 M 9.02 M - 5 M 4.96 M 4.94 M - 4.87 M 4.81 M 4.8 M - 5.94 M 5.22 M 5.18 M - 4.77 M 3.44 M 3.42 M

EBITDA

-147 M - - - -112 M - -47.9 M -78 M -53.8 M 221 M -74.2 M -65 M -88.1 M -22.7 M -26.8 M -45.4 M -57.9 M 261 M 11.9 M -12.6 M 125 M 10.8 M -10.9 M -45.4 M -938 K -6.2 M 17.4 M 10.4 M 21.5 M 41.2 M 21.7 M -45.2 M -52.8 M -62.9 M -42.9 M 48.1 M -7.76 M 10.1 M -16.7 M -3.51 M -28.1 M -19.9 M -20.5 M -4.55 M 3.33 M -26.1 M -28 M 3.7 M -18.5 M -18.6 M -22.3 M -14.1 M -16.1 M

Operating Expenses

- - - - - - - - - - - - - - - - - - - - - 181 M 164 M 168 M 148 M 174 M 107 M 106 M 96.3 M 119 M 94.8 M 87.4 M 91.5 M 115 M 97.3 M 75.8 M 71.9 M 74.8 M 65.6 M 63.7 M 57.8 M 62.1 M 49.1 M 46 M 41.7 M 46 M 39.6 M 43.6 M 41.7 M 51 M 43 M 38.9 M 37.3 M

General and Administrative Expenses

52.6 M - 70 M 46.1 M 45.5 M - 34.4 M 33.8 M 34.1 M - 31.1 M 56.5 M 61.2 M - 68.4 M 72 M 75 M - 60 M 75.1 M 68.2 M - 68.7 M 66.2 M 43.7 M - 26.8 M 22.3 M 13.7 M - 10.2 M 9.82 M 10.6 M - 8.75 M 7.78 M 7.47 M - 4.47 M 4.46 M 4.38 M - 3.43 M 3.39 M 3.42 M - 3.1 M 3.21 M 2.98 M - 3.1 M 2.87 M 3.01 M

All numbers in USD currency